Advanced search

Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada

(2005) JOURNAL OF CLINICAL ONCOLOGY. 23(28). p.6881-6889
Author
Organization

Citation

Please use this url to cite or link to this publication:

Chicago
Van Meerbeeck, Jan, R GAAFAR, C MANEGOLD, RJ VAN KLAVEREN, EA VAN MARCK, M VINCENT, C LEGRAND, A BOTTOMLEY, C DEBRUYNE, and G GIACCONE. 2005. “Randomized Phase III Study of Cisplatin with or Without Raltitrexed in Patients with Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.” Journal of Clinical Oncology 23 (28): 6881–6889.
APA
Van Meerbeeck, J., GAAFAR, R., MANEGOLD, C., VAN KLAVEREN, R., VAN MARCK, E., VINCENT, M., LEGRAND, C., et al. (2005). Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. JOURNAL OF CLINICAL ONCOLOGY, 23(28), 6881–6889.
Vancouver
1.
Van Meerbeeck J, GAAFAR R, MANEGOLD C, VAN KLAVEREN R, VAN MARCK E, VINCENT M, et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005;23(28):6881–9.
MLA
Van Meerbeeck, Jan, R GAAFAR, C MANEGOLD, et al. “Randomized Phase III Study of Cisplatin with or Without Raltitrexed in Patients with Malignant Pleural Mesothelioma: An Intergroup Study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada.” JOURNAL OF CLINICAL ONCOLOGY 23.28 (2005): 6881–6889. Print.
@article{332394,
  author       = {Van Meerbeeck, Jan and GAAFAR, R and MANEGOLD, C and VAN KLAVEREN, RJ and VAN MARCK, EA and VINCENT, M and LEGRAND, C and BOTTOMLEY, A and DEBRUYNE, C and GIACCONE, G},
  issn         = {0732-183X},
  journal      = {JOURNAL OF CLINICAL ONCOLOGY},
  language     = {eng},
  number       = {28},
  pages        = {6881--6889},
  publisher    = {AMER SOC CLINICAL ONCOLOGY},
  title        = {Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: An intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada},
  volume       = {23},
  year         = {2005},
}

Web of Science
Times cited: